NCT07692165: A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 24 planned
- Started
- 11 Jun 2026
- Primary completion
- Jun 2028
- Arms
- 200 mg INT-210 capsule, 400 mg INT-210 capsule
- Results
- None posted
- 11 Jun 2026: Trial started
- 9 Jul 2026: Trial registered